Complement as a Natural Adjuvant to Promote Anti-Tumor Immunity in Cancer Therapy
Time: 12:00 pm
day: Day Two
Details:
- Exploring how the complement system interacts with the tumor microenvironment in driving anti-tumor immunity in cancer
- Human-derived antibodies can cause complement activation, tumor-specific cytotoxicity, and anti-tumor immunity
- Evaluating implications for metrics in measuring success of complement therapy in cancer, and subsequent novel trial design
